Roger A. Moorehead
Impact in
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
- NF-κB Signaling Pathways
- Oncology top 2%
- Cancer Cells and Metastasis
- Bone health and treatments
Papers in
-
- Cancer-related molecular mechanisms research 12
- Cancer, Hypoxia, and Metabolism 12
- MicroRNA in disease regulation 9
-
- Growth Hormone and Insulin-like Growth Factors 18
- Co-authors
- Rama KhokhaJimmie E. FataJim PetrikJames GreenawayKevin J. LecoEvelyn B. VouraGurmit SinghRobert A. Jones
- Journals
- Oncogene (6 papers)BMC Cancer (5 papers)PLoS ONE (5 papers)Cancer Cell International (4 papers)Oncotarget (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Roger A. Moorehead
68 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 1.0k
- Oncology 1.1k
- Molecular Biology 1.8k
- Immunology and Allergy 116
- Endocrinology, Diabetes and Metabolism 284
Countries citing papers authored by Roger A. Moorehead
This map shows the geographic impact of Roger A. Moorehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger A. Moorehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger A. Moorehead more than expected).
Fields of papers citing papers by Roger A. Moorehead
This network shows the impact of papers produced by Roger A. Moorehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger A. Moorehead. The network helps show where Roger A. Moorehead may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger A. Moorehead, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 4 | |
| 7 | 2018 | 21 | |
| 8 | 2015 | 10 | |
| 9 | 2014 | 4 | |
| 10 | 2013 | 10 | |
| 11 | 2011 | 19 | |
| 12 | 2010 | 10 | |
| 13 | 2010 | 11 | |
| 14 | 2008 | 17 | |
| 15 | 2008 | 20 | |
| 16 | 2007 | 78 | |
| 17 | The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development Hit paper breakdown → | 2000 | 596 |
| 18 | 2000 | 33 | |
| 19 | 1997 | 56 | |
| 20 | 1996 | 5 |
About Roger A. Moorehead
Roger A. Moorehead is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Oncology, Molecular Biology and Immunology and Allergy, having authored 69 papers that have together received 2.8k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (18 papers), Cancer Cells and Metastasis (15 papers), Cancer-related molecular mechanisms research (12 papers), Cancer, Hypoxia, and Metabolism (12 papers), MicroRNA in disease regulation (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Metabolism, Diabetes, and Cancer (9 papers) and Angiogenesis and VEGF in Cancer (7 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.1k citations), Molecular Biology (1.8k citations), Immunology and Allergy (116 citations) and Endocrinology, Diabetes and Metabolism (284 citations). Roger A. Moorehead has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Rama Khokha, Jimmie E. Fata, Jim Petrik, James Greenaway, Kevin J. Leco, Evelyn B. Voura, Gurmit Singh, Robert A. Jones, Craig I. Campbell and Junko Irie-Sasaki. Their work appears in journals such as Oncogene, BMC Cancer, PLoS ONE, Cancer Cell International and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.